[ad_1] The inhibitor of EGFR TKI, Technology transfer to global pharmaceutical company Janse Biotech, a subsidiary of J & J Deposit of 56 billion won, step by step of 1.35 trillion wonGlobal …
Read More »[ad_1] The inhibitor of EGFR TKI, Technology transfer to global pharmaceutical company Janse Biotech, a subsidiary of J & J Deposit of 56 billion won, step by step of 1.35 trillion wonGlobal …
Read More »